NAVA — Navamedic ASA Cashflow Statement
0.000.00%
Last trade - 00:00- NOK471.23m
- NOK596.00m
- NOK565.36m
Annual cashflow statement for Navamedic ASA, fiscal year end - December 31st, NOK millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.36 | 42.5 | 10.8 | -1.62 | — |
| Depreciation | |||||
| Non-Cash Items | 6.21 | -0.808 | 12.7 | 4 | — |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -16.6 | -31 | -33.2 | -3.36 | 24.2 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.3 | 17.9 | 2.18 | 39.4 | 24.2 |
| Capital Expenditures | -0.728 | -2.25 | -2.2 | -3.33 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.001 | -23.2 | -102 | 0.547 | -187 |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.727 | -25.4 | -105 | -2.78 | -187 |
| Financing Cash Flow Items | -1.47 | -3.27 | -7.23 | -7.78 | 193 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.9 | 10.1 | 83.2 | -37.7 | 193 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13 | 2.68 | -17.3 | -0.751 | 36.9 |